U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing

Johnson & Johnson's sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country's stringent medical device pricing policies.


from Reuters: Top News https://reut.rs/2CMzZii Johnson & Johnson's sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country's stringent medical device pricing policies.

Related Posts:

0 comments:

Post a Comment

Sample Text

Blog Archive

Powered by Blogger.

Social Widget